Skip to main content

Table 2 Changes in SER, UCVA, AL and topographic map parameters after orthokeratology treatment

From: Efficacy of orthokeratology lens with the modified small treatment zone on myopia progression and visual quality: a randomized clinical trial

Variable (mean ± SD)

STZ group (n = 68)

CTZ group (n = 63)

t value

P value

SER at 1 month (D)

0.04 ± 0.57

0.05 ± 0.45

 − 0.110

0.913

UCVA at 1 month (logMAR)

0.00 ± 0.01

0.02 ± 0.12

 − 0.974

0.332

AL changes at 6 months (mm)

0.01 ± 0.09

0.05 ± 0.09

 − 2.266

0.025*

AL changes at 12 months (mm)

0.07 ± 0.11

0.14 ± 0.12

 − 3.291

0.001*

AL changes at 18 months (mm)

0.17 ± 0.15

0.26 ± 0.16

 − 3.407

0.001*

Changes in HOA (μm)

0.90 ± 0.43

0.71 ± 0.47

2.292

0.024*

Changes in total SA (μm)

0.37 ± 0.25

0.25 ± 0.29

2.477

0.015*

TZ diameter (mm)

2.50 ± 0.23

2.77 ± 0.18

 − 7.529

 < 0.001*

TZ area (mm2)

4.94 ± 0.89

6.05 ± 0.82

 − 7.425

 < 0.001*

Defocus ring width (mm)

2.45 ± 0.28

2.30 ± 0.30

2.814

0.006*

Total amount of defocus (D·mm2)

119.38 ± 63.71

91.40 ± 40.83

3.015

0.003*

Distance of decentration (mm)

0.41 ± 0.16

0.41 ± 0.16

0.096

0.923

  1. Normally distributed data were expressed as mean ± standard deviation
  2. SER = spherical equivalent refraction; UCVA = uncorrected visual acuity; AL = axial length; HOA = higher-order aberration; SA = spherical aberration; TZ = treatment zone; Total amount of defocus = the total value of defocus·area (D·mm2); n = number of subjects
  3. *P < 0.05 indicates statistical significance